Actively Recruiting

Age: 18Years - 85Years
All Genders
ID07148518

Comparison of Upper and Lower Limb Maximal Exercise Capacities, Arterial Stiffness, Muscle Oxygenation and Energy Consumption During Tests in Patients With Coronary Artery Disease

Led by Gazi University · Updated on 2026-02-03

30

Participants Needed

1

Research Sites

14 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Coronary artery disease (CAD) causes reduced blood flow to the heart muscle, leading to symptoms like chest pain, breathlessness, and tiredness. Patients often avoid physical activity due to fear of chest pain, which lowers their exercise capacity. This study aims to compare the exercise abilities and arterial stiffness during exercise tests involving both the upper and lower limbs in people with CAD. It also evaluates muscle oxygen levels, energy use, and feelings of breathlessness and fatigue during these tests. Participants undergo two main exercise tests. The first test measures the maximal exercise capacity of the lower limbs using a treadmill while monitoring muscle oxygenation and energy use. Arterial stiffness and respiratory muscle fatigue are measured before and after this test. The second test, performed 48 hours later, measures the maximal exercise capacity of the upper limbs using an arm ergometer with similar monitoring and pre- and post-test evaluations. During the study, participants will have ongoing assessments of their exercise capacities, arterial stiffness, muscle oxygenation, respiratory muscle fatigue, energy consumption, and perceptions of breathlessness and fatigue. These measurements will be tracked for about one year. The study helps understand differences between upper and lower limb exercise in CAD patients and may provide insights for tailored exercise programs.

CONDITIONS

Brief Title

Comparison of Upper and Lower Limb Maximal Exercise Capacities and Arterial Stiffness in Patients With CAD

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18-85 with coronary artery disease diagnosed by conventional or CT angiography
  • Clinically stable
  • Willing to participate
Not Eligible

You will not qualify if you...

  • Heart failure diagnosis
  • Moderate/severe valvular heart disease
  • Orthopedic, neurological, or pulmonary conditions limiting exercise testing/capacity
  • Contraindications per ACSM guidelines
  • Prior coronary artery bypass graft surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 2 days

Participants undergo two cardiopulmonary exercise tests to evaluate maximal exercise capacities of the lower and upper extremities, arterial stiffness, muscle oxygenation, energy consumption, respiratory muscle fatigue, and perceptions of dyspnea and fatigue.

2 visits (in-person) spaced 48 hours apart

Long-term Monitoring

Duration - Up to 1 year

Participants are observed for outcomes including exercise capacity, arterial stiffness, muscle oxygenation, energy consumption, muscle strength, pulmonary function, physical activity level, chronotropic response, and perceptions of dyspnea and fatigue over approximately 1 year.

Visit schedule not specified

Trial Site Locations

Total: 1 location

1

Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit, Ankara, Çankaya 06490

Ankara, Çankaya, Turkey (Türkiye), 06490

Actively Recruiting

Loading map...

Research Team

M

Meral BOŞNAK GÜÇLÜ, Prof. Dr.

N

Naciye SEVİM, Pt.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Erectile Function After Percutaneous Coronary Intervention i...

Erectile Disfunction

Actively Recruiting

1 location

A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Seq...

Coronary Artery Disease (CAD)

Actively Recruiting

1 location

AI Facial Analysis Algorithm to Screening Coronary Artery Di...

Coronary Artery Disease (CAD)

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

GBD 2013 Mortality and Causes of Death Collaborators

https://pubmed.ncbi.nlm.nih.gov/25530442

The isokinetic assessment of peripheral muscle function in patients with coronary artery disease: correlations with cardiorespiratory capacity.

S Ghroubi, M Chaari, H Elleuch...

https://pubmed.ncbi.nlm.nih.gov/17449129

Kinesiophobia, physical performance, and health-related quality of life in patients with coronary artery disease.

Beyza Çakal, Meriç Yıldırım, Sadık Volkan Emren

https://pubmed.ncbi.nlm.nih.gov/36751297

Arterial Stiffness is Related to Impaired Exercise Capacity in Patients With Coronary Artery Disease and History of Myocardial Infarction.

Alberto Jorge Alves, Norton Luís Oliveira, Susana Lopes...

https://pubmed.ncbi.nlm.nih.gov/30318391